Prospective study of ventricular function and myocardial deformation related to survival in acute Chagas disease: an experimental animal model by Vargas, Arthur Lauand et al.
Rev Inst Med Trop São Paulo. 2021;63:e61 Page 1 of 9
ORIGINAL ARTICLE
http://doi.org/10.1590/S1678-9946202163061
This is an open-access article distributed under the 
terms of the Creative Commons Attribution License.
1Universidade de São Paulo, Faculdade 
de Medicina de Ribeirão Preto, Centro de 
Cardiologia, Ribeirão Preto, São Paulo, 
Brazil
Correspondence to: Minna Moreira Dias 
Romano 
Universidade de São Paulo, Faculdade 
de Medicina de Ribeirão Preto, Centro de 
Cardiologia, Avenidas dos Bandeirantes, 
3900, CEP 14.049-900, Ribeirão Preto, SP, 
Brazil 
E-mail: minna@fmrp.usp.br
Received: 23 March 2021
Accepted: 23 June 2021
Prospective study of ventricular function and myocardial 
deformation related to survival in acute Chagas disease: an 
experimental animal model
Arthur Lauand Vargas1, Beatriz de Paula Dias 1, Henrique Turin Moreira1, 
Edgard Camilo de Oliveira-Filho1, Denise Mayumi Tanaka1, Marcus Vinicius 
Simões1, Benedito Carlos Maciel1, André Schmidt 1, José Antônio 
Marin-Neto 1, Minna Moreira Dias Romano 1
ABSTRACT
Chagas disease (CD) has been changing from an endemic Latino-American disease to 
a condition found outside endemic regions, due to migratory movements. Although often 
subclinical, its acute phase can be lethal. This study aimed to assess survival during the 
acute phase of CD and its relationship with ventricular function in an experimental model. 
To this end, 30 Syrian hamsters were inoculated with Trypanosoma cruzi (IG) and other 
15 animals received saline solution (CG). Groups were monitored daily and submitted to 
echocardiography in two moments: before the challenge and 15 days post-infection. Left 
ventricular ejection fraction (LVEF) and global longitudinal myocardial strain (GLS) of the 
LV were measured. The IG was divided into groups of animals with and without clinical signs 
of disease. ANOVA for mixed models was used to compare ventricular function parameters. 
Survival analysis was studied using Kaplan-Meier curves and the log-rank test. The follow-up 
lasted 60 days. LVEF in IG was reduced through time (53.80 to 43.55%) compared to CG 
(57.86 to 59.73%) (p=0.002). There was also a reduction of GLS (-18.97% to -12.44%) in 
the IG compared to CG (p=0.012). Twelve animals from IG died compared to one animal 
from CG. Eleven out of the 12 animals from the IG group died before presenting with clinical 
signs of infection. Survival was reduced in the IG compared to CG over time (p=0.02). The 
reduced survival during the acute phase of this experimental model of Chagas disease was 
related to the significant reduction of LV function. The mortality rate in the IG was higher 
in the group presenting with clinical signs of infection.
KEYWORDS: Echocardiography. Acute Chagas disease. Speckle-tracking. Animal 
experimental model. Ventricular function. Myocardial deformation.
INTRODUCTION 
Chagas disease (CD) is endemic in Latin America, with more than 8 million 
people infected by the protozoan Trypanosoma cruzi1-3. Migration has spread disease 
to Europe and North America, with an increased number of cases in the last decade4,5. 
Although vector transmission rates were reduced in endemic regions, non-vector 
oral transmission or secondary to transfusion and solid organ transplantation are still 
prevalent6. Reactivation of disease in scenarios of immunosuppression, as happens 
in heart transplant patients, is a particular and dangerous situation7,8. 
In Brazil, acute CD is the main infectious disease impacting patients’ quality 
of life, overcoming the Dengue virus infection1. The acute phase of CD is mostly 
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asymptomatic, but it can be lethal for a proportion of 
patients, probably secondary to acute myocarditis9,10. 
Among children and young adults who develop symptoms, 
ventricular dysfunction is not always identified but defines 
a poor outcome when is present9. Although human studies 
of cases series have reported myocarditis and high mortality 
rates in the acute phase of CD11, some animal explorations 
failed to show consistent ventricular dysfunction12.
As prospective studies in humans are limited by the 
characteristics of Chagas disease, animal models became 
useful to explore evolutionary aspects of cardiac function 
with great resemblance to human disease13. The Syrian 
hamster model has been described to mimic all phases 
of Chagas disease with a searchable timeline, early 
myocardial lesion detection and progression to chronic 
cardiomyopathy14,15. Echocardiography is an accurate 
and non-invasive tool for the investigation of Chagas 
cardiomyopathy, assessing left ventricle (LV) geometry and 
function through the evolution of CD16. New developments 
such as dedicated small animal equipment and high-
resolution transducers17, in addition to new techniques like 
Speckle Tracking Echocardiography (STE), have enhanced 
the ability to study early myocardial damage in CD18-20. 
This study aimed to prospectively evaluate LV geometry 
and myocardial function and their relationships with 
survival in the acute phase of an animal model of CD. 
Specific objectives were [1] to assess survival during the 
acute phase of CD and its association with LV impairment; 
[2] to associate the clinical presentation of the animals in 
the acute phase with the outcome death; [3] to evaluate if 
STE parameters have prognostic value.
MATERIALS AND METHODS
Experimental animal model
Forty-five 12-week old female Syrian hamsters 
(Mesocricetus auratus) were kept in a climate-controlled 
environment with free access to water and standard chow 
under a twelve-hour light/dark cycle. Animals were 
submitted to all experimental procedures under anesthesia 
with Ketamine (100 mg/kg) and Xylazine (10 mg/kg) to 
avoid pain. The study and all experimental procedures 
were approved by the Institutional Animal Research Ethics 
Committee (protocol Nº 223/2018).
Experimental protocol
Animals (n=45) were randomly separated into 
two groups: the control group (CG) composed of 
15 animals injected with saline solution and the infected 
group (IG) with 30 animals. The infected group was 
intraperitoneally inoculated with 35,000 trypomastigote 
forms of Trypanosoma cruzi (Y strain) and had the infection 
confirmed by a parasite DNA detection in a blood sample 
by Polymerase Chain Reaction (PCR). The control group 
was injected with an equal volume of saline solution 
(0.2  mL). Animals were daily monitored and submitted 
to echocardiography in two different moments: before the 
challenge (baseline) and 15 days post-infection. Clinical 
signs of acute Chagas disease were characterized by at least 
one of the following: weight loss, mucous wounds, fur loss 
or lethargy. The ollow-up lasted 60 days and the survivors 
rate and time to death were counted. 
Echocardiography
Examinations were performed with the equipment 
Vevo2100 (Fujifilm Inc., Japan) ultrasound system provided 
with a 30-MHz high-resolution transducer that is dedicated 
to small animals Parasternal long and short axis view were 
obtained. Left ventricular end-diastolic diameter (LVEDD) 
and left ventricular end-systolic diameter (LVESD) were 
obtained at the maximum ventricular diastolic dimension, 
and LVESD at the maximum inward motion of the septum 
and posterior wall, respectively. The left ventricular mass 
(LV mass) was estimated by the Devereux formula using 
thickness measurements of the septum and posterior wall. 
LVEDD and LV mass were also presented as indexed 
measures when divided by the animal weight. The LV 
fractional shortening (FS) was calculated from LVEDD 
and LVESD measurements. The left ventricle ejection 
fraction was measured by the M-mode (LVEF_MMode) at 
parasternal long axis view using the Teichholz formula. The 
LVEF_2D was calculated using parasternal short axis view 
measurements of volumes by the method of area-length. 
All images were recorded by the same investigator (BPD), 
experienced in small animals experiments and analyzed 
offline by three investigators, ALV, BPD, and MMDR, the 
last one, a specialist in human echocardiography.
Speckle tracking echocardiography 
The global LV myocardium deformation analysis in 
three axes, longitudinal, circumferential and radial was 
performed. The global longitudinal strain (GLS) was 
obtained in a parasternal long axis view, while global 
circumferential strain (GCS) and radial strain (GRS) 
were measured in a parasternal short axis view. The two-
dimensional speckle-tracking analysis was applied to assess 
LV deformation using the validated Vevo® Strain Software 
(VisualSonics Inc., Toronto, Canada). The end-diastole was 
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automatically defined at the peak of the QRS complex. The 
end-systolic time was defined as the point of the smallest 
dimension of the LV cavity and visually checked by using 
the position of mitral leaflets in the background image in 
M20-mode20.
 The manual LV endocardial border delineation was 
performed in the parasternal long axis view to measure 
GLS or short axis view, in order to measure GRS and 
GCS. Thereafter, epicardial borders were automatically 
defined, creating a region of interest. If necessary, a manual 
adjustment in the region of interest was made to include the 
entire region of LV myocardium, excluding the pericardium, 
based on a six-segment model21 in each projection. Finally, 
visual quality control in myocardium tracking was applied, 
and a retracking was performed when at least one segment 
was poorly tracked. 
In the presence of a persistent poor tracking of at least 
one segment per projection, the global deformation analysis 
was considered not feasible. The LV deformation was 
measured as the peak systolic change in the myocardial 
length relative to the length at the end of diastole represented 
by a percentage of change (%). Negative values represent 
longitudinal and circumferential myocardial deformation 
and positive values represent radial deformation.
Reproducibility
The reproducibility analysis of echocardiographic LVEF 
and STE parameters was performed in 20 randomly selected 
animals. For the intra-observer reproducibility, a rereading 
was carried out at least 60 days after the first reading, 
blinded to the previous results. For the inter-observer 
analysis, the second independent reader was blinded to 
the analysis of the first reader. Inter- and intra-reader 
reproducibility analyses were evaluated using an intra-class 
correlation coefficient (ICC) to assess absolute agreement 
and a coefficient of variation (CV), determined by the 
standard deviation divided by the mean, and expressed in 
percentage.
Statistical analysis
Continuous data presented normal distribution when 
assessed by histograms and the Shapiro-Wilk test, and are 
expressed as mean ± standard deviation (SD). Categorical 
data are presented as absolute values and percentages. 
The student t-test was used to evaluate differences 
between the two groups at baseline and 15 days after the 
echocardiographic examinations. 
The analysis of variance for mixed models of repeated 
measures (mixed-ANOVA) was used to evaluate interaction 
(main effect) between the experimental groups (between-
subject effect) and time (within-subject effect). The 
survival analysis was studied using Kaplan-Meier curves 
and comparison between groups used the log-rank test. 
The statistical analysis was performed using Minitab 17 
(Minitab Inc. 2010, State College, PA, USA) and Stata 14.0 
(StataCorp, College Station, TX, USA), and P-values < 0.05 
were considered statistically significant. 
RESULTS
A total of 45 animals were evaluated by echocardio-
graphy. At baseline (Table 1), animals in the CG and 
IG groups had similar weight but the heart rate of the 
T. cruzi-infected group was statistically superior to the 
controls (184.9 ± 19.7 vs 161.4 ± 26.1 bpm; p = 0.009). 
Echocardiographic variables of LV geometry showed 
a significantly higher value of LVEDD in the chagasic 
group compared to CG (6.5 ± 0.3 vs 6.0  ±  0.5  mm; 
p  = 0.003), but the difference was not present when 
LVEDD was indexed according to the animals’ weight 
(5.04 ± 0.42 vs 5.01 ± 0.42; p = 0.286).
LVEF measured with both methods (MMode and 2D) 
and FS, LV mass, and STE parameters as GLS and GRS were 
not different between groups. However, GCS was reduced 
in the T. cruzi-infected group (–19.5 ± 3.1 vs –22.9 ± 5.6; 
p = 0.0456).
At 15 days after infection, chagasic animals had reduced 
weight, increased heart rate, and reduced absolute LVEDD, 
although LVEDD indexed to body weight was increased 
when compared to the control group. All LVEF and FS 
measurements decreased in the T. cruzi-infected group, 
with an elevated LVESD. All STE parameters were reduced 
in T. cruzi-infected group compared to CG. All data and 
statistical comparisons are shown in Table 2. 
Survival in the T. cruzi-infected group was significantly 
reduced (40% vs 6.6%; p=0.03) and log-rank comparison 
of survival Kaplan-Meier curves (p = 0.02). Mortality in 
the T. cruzi-infected group occurred from day 19 to day 
23 post-infection. All the 12 dead animals in the T. cruzi-
infected group presented with one or more of the clinical 
signs of disease. The only dead animal in the control group 
did not present with clinical signs of disease. The survival 
analysis is shown in Figure 1.
Sequential analysis of LV functional parameters 
showed that 15 days after the challenge, chagasic animals 
evolved with reduced LVEF according to all methods with 
a p-value for interaction equal to 0.003 for LVEF_2D 
(Figure 2) and a p-value for interaction equal to 0.005 for 
LVEF_MMode and a p-value for interaction equal to 0.013 
for FS. STE parameters analyses showed that GLS was also 
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significantly impaired through time in the chagasic group 
with a p-value for interaction equal to 0.012 (Figure 3A). 
Reductions in GCS and GRS through time in the T. cruzi-
infected group were not statistically significant (p-value for 
Table 1 - Basal characteristics of animals, the control group vs T. cruzi-infected group.
Control Chagas p
n 15 30
Weight (g) 120.7 ± 7.9 124.87 ± 9.95 0.139
HR (bpm) 161.4 ± 26.1 184.9 ± 19.7 0.009
ECHO 
LVEDD (mm) 6.0 ± 0.5 6.5 ± 0.3 0.003
LVESD (mm) 4.4 ± 0.5 4.7 ± 0.3 0.091
LVEF_2D (%) 57.9 ±7.5 53.8 ± 4.9 0.072
LVEF_MMode (%) 50 ± 11,1 52.7 ± 4.9 0.376
FS (%) 26.5 ± 7.0 27.8 ± 3.2 0.485
LV mass (mg) 427.9 ± 77.5 431.9 ± 56.5 0.862
LV mass/w (g/hg) 354.02 ± 58.7 346.89 ± 45.4 0.698
LVEDD/w (cm/hg) 5.01 ± 0.42 5.04 ± 0.42 0.286 
GLS (%) -19.59 ± 4.0 -18.6 ± 3.9 0.456
GRS (%) 30.19 ± 8.67 28.54 ± 6.7 0.538
GCS(%) - 22.9 ± 5.6 - 19.5 ±3.1 0.046
Bpm = beats per minute; g = grams; g/hg = grams/hectograms; mm = millimeter; mm/hg = millimeter per hectagram; mg = milligram. 
HR = heart rate; LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end systolic diameter; LVEF_2D = left ventricle 
ejection fraction (2D); LVEF_MMode = left ventricle ejection fraction (MMode); FS = fractional shortening; GLS = global longitudinal 
strain; GCS = global circumferential strain; GRS = global radial strain.
Table 2 - Characteristics of animals (control group vs T. cruzi-infected group) 15 days post-infection.
Control Chagas p
n 15 30
Weight (g) 131.1 ± 6.7 108.4 ± 27.4 <0.05
HR (bpm) 151.1 ± 25.2 191.7 ± 46.5 <0.05
Clinical signs (%) 0 50
Mortality rate (%) 6.6 40 0.02
ECHO
LVEDD (mm) 6.3 ± 0.3 5.86 ± 1.1 0.047
LVESD (mm) 4.2 ± 0.3 4.47 ± 1.1 0.035
LVEF_2D (%) 59.7 ± 5.9 43.6 ± 12.1 <0.05
LVEF_MMode (%) 59.3 ± 8.1 46.6 ± 14.6 <0.05
FS (%) 32.5 ± 5.7 24.6 ± 10.3 <0.05
LV mass (mg) 456.2 ± 59.2 526.5 ± 113.9 <0.05
LV mass/w (g/hg) 348.6 ± 46.5 488.1 ± 81.1 <0.05
LVEDD/w (mm/hg) 4.8 ± 0.3 5.29 ± 1.3 0.002 
GLS (%) -19.7 ± 4.0 -13.5 ± 4.8 <0.05
GRS (%) 35.1 ± 10.2 25.5.1 ± 7.7 <0.05
GCS(%) -21.9 ± 4.3 -17.3 ± 4.7 <0.05
bpm = beats per minute; g = grams; g/hg = grams/hectograms; mm = millimeter; mm/hg = millimeter per hectagram; mg = milligram. 
HR = heart rate; LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end systolic diameter; LVEF_2D = left ventricle 
ejection fraction (2D); LVEF_Mmode = left ventricle ejection fraction (MMode); FS = fractional shortening; GLS = global longitudinal 
strain; GCS = global circumferential strain; GRS = global radial strain.
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interaction equal to 0.0493 and 0.069, respectively) when 
they were analyzed through ANOVA of mixed models with 
group#time interactions (Figures 3B and 3C).
The reproducibility analysis of LVEF and STE 
revealed ICC ranging from 0.67 (for GRS) to 0.91 (for 
GLS). The LVEF_MMode method showed the lowest 
inter-reader coefficient of variation (5.66%), while GRS 
exhibited the highest coefficient (13.63%). The intra-reader 
reproducibility showed an ICC ranging from 0.49 (for 
LVEF_2D) to 0.92 (for GLS) and a coefficient of variation 
from 4.25% (for LVEF_MMode) to 10.85% (for GRS).
DISCUSSION
The acute phase of CD is well reproduced in the 
Syrian hamster animal model with a high mortality rate in 
comparison with the control group. Mortality happened from 
day 19 to day 23 post-infection and was preceded by clinical 
signs in all CD animals. When studied by echocardiography 
15 days post-infection, T. cruzi-infected animals presented 
with increased LVEDD/w, increased LVESD and reduced 
LVEF. Furthermore, the STE parameter of longitudinal 
deformation, GLS, was reduced at this time of the disease 
evolution in the T. cruzi-infected group. 
Cardiac alterations described in human clinical records of 
the acute phase of vector-transmitted CD include pericardial 
Figure 1 - Survival analysis using Kaplan-Meier curves from 
both groups (controls and T. cruzi- infected group) during the 
follow-up.
Figure 2 - LVEF_2D evolution through time in controls and T. 
cruzi-infected group.
Figure 3 - Myocardial deformation indices: GLS (A), GCS (B) 
and GRS (C), evolution through time in controls vs T. cruzi-
infected group.
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effusion, LV regional myocardial dysfunction, valvar 
regurgitations, and, in a proportion of patients, global LV 
dysfunction, which can be normalized with the etiological 
treatment8,9,22. In the non-vector transmission, such as oral 
or solid organ transplantation, the LV global dysfunction, 
presenting as acute myocarditis has been described and 
clinical evolution can be dramatic6. Mortality in the acute 
phase of human CD is described in 5% to 10 % of cases22. 
This animal model of CD was already known to reproduce 
the chronic CD cardiomyopathy, with mortality rates near 
50%, at 9 to 11 months of evolution15,23. However, this study 
shows the ability of this model to also reproduce the acute 
phase of the disease, with left ventricle geometry and systolic 
function alterations in the first 15 days after infection. Acute 
myocarditis with LV dysfunction is responsible for the major 
proportion of mortality (40%) through the complete evolution 
of the disease in the animal model.
Some previous studies with other animal models of 
CD failed to demonstrate the presence of consistent left 
ventricular dysfunction. Lima et al.12, studying T. cruzi-
inoculated rhesus monkey by means of bidimensional 
echocardiography, did not show any difference in LVEDD 
or its area, neither in the systolic change of LV area even 
in the presence of several degrees of myocarditis in the 
tissue analysis. This study was conducted in a remote time 
of the echocardiography evolution, which could explain 
the lack of sensitivity to evaluate LV geometry and systolic 
function by the method. Other studies in small animal 
models as mice have also demonstrated myocarditis in 
the tissue analysis, but not all of them correlated it to the 
ventricular function evaluation24. Jeliks et al.25, however, 
using gated magnetic cardiac resonance in a mice model 
of CD, demonstrated that LVEDD, as well as RVEDD, 
increased in acute CD, although these authors have not yet 
reported data of ventricular function. After this, the same 
group demonstrated a reduced LV fractional shortening 
(FS) in this rodent animal model of acute CD, which could 
be used as a parameter of response to treatments26. Left 
ventricle FS was, since then, used in other animal studies 
as an echocardiography variable capable to demonstrate 
systolic LV dysfunction in acute CD but there are still 
some controversies23,27. Difficulties may be related to the 
fact that FS is generated from a unidimensional linear LV 
measurement and it is not able to represent segmental LV 
myocardial hypokinesia. The use of bidimensional methods 
to measure LVEF has been recently applied to small animal 
models of cardiac disease, following the development of a 
dedicated equipment with high-resolution transducers17,28. 
Our data showed a consistently reduced LV systolic function 
in the first 15 days of infection, measured by three different 
echocardiographic methods: FS, LVEF from MMode and the 
bidimensional mode. In addition, a significant geometrical 
remodeling is demonstrated in this animal model in the acute 
phase of CD, with increments of LVmass, LVEDD/w and 
LVESD. Thus, an acute dilated cardiomyopathy has been 
well demonstrated in the acute phase of CD in the Syrian 
hamster animal model with this study.
The left ventricle deformation analysis in the acute 
phase of CD in our study was significantly reduced. GLS 
was statistically reduced in chagasic animals compared 
to controls 15 days after challenge, however, GCS and 
GRS reduction trends were not statistically significant. 
Statistical differences noted in simple group comparisons 
were not confirmed when using the mixed-ANOVA 
model, which adjusts exposition to infection and time of 
evolution together. The GLS behavior is not well known 
through the acute phase of CD. Previous studies in humans 
showed that, through the evolution of CD, individuals 
in the indeterminate phase of the disease do not present 
with a significant reduction of GLS18,19,29, but no data 
about LV deformation indexes were demonstrated in the 
acute phase. As mortality happens in the acute phase, it is 
plausible that survivals from the acute phase undergoing 
the chronic phase, even if presenting with indeterminate 
forms of CD, are those who do not have dysfunction in 
the acute phase. GLS is known as a sensitive parameter 
of myocardial dysfunction that can be depressed in the 
early phases of other non-ischemic myocardial diseases. 
However, considering its reduction in the acute phase, 
together with other LV geometric and classic functional 
parameters as LVEF, it does not represent early cardiac 
damage, but an overt expressed acute myocarditis. The 
influence of the heart rate in the echocardiographic 
analysis of myocardium deformation parameters is always 
a technical concern. We have previously published data 
showing little influence of the heart rate in the longitudinal 
myocardial deformation analysis in normal Hamsters, 
using the same equipment20. Although animals were not 
infected in the previous publication, the heart rate range 
was 204 ± 24 bpm, and it was even superior in comparison 
with the T. cruzi-infected group of the present study. 
The same previous study showed that the animals weigh 
had no significant influence in myocardial deformation 
parameters.
 The measurement of GRS has yielded more controversial 
data in studies on patients with diverse forms of chronic 
CD18,29. Although chronic Chagas disease presents typical 
myocardial damage of meso-myocardium fibrosis30, 
presuming that GCS and GRS should be more compromised, 
once this myocardium deformation direction represents 
essentially the meso-myocardial fiber function, our study 
showed that these parameters are still not significantly altered 
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in acute CD. High variability of GRS is still a recognized 
problem of the technique that can be explained by several 
factors, such as image formation and tracking of speckles31. 
However, we should also consider inflammation as a more 
prominent mechanism of acute CD32 than myocardial fibrosis, 
and also question if GCS and GRS can demonstrate it. 
Limitations 
Our findings should be interpreted in the context of 
several limitations. At first, the fact that only animals who 
had all echocardiographic analyses in both time points 
were included, according to the inherent characteristic of 
the mixed-ANOVA analysis. Secondly, this study did not 
present the tissue analysis, as deaths were spontaneous 
and the short time interval of the acute phase did not 
allow euthanasia of the very sick animals. Finally, it is 
also important to consider that anesthetic agents could 
influence parameters such as the myocardial performance. 
Although isoflurane is considered by some authors as a 
more superficial anesthetic agent, it has significant effects 
on cardiac function evaluated by LVEF33. Animals in this 
study used ketamine based on the fact that it has been shown 
to have fewer effects on LVEF and that it has been already 
tested in hamsters34. Nevertheless, there is a lack of data 
in the literature about the impact of anesthetic agents in 
myocardial deformation parameters. 
Translational aspects and future perspectives 
In acute CD, early and sequential monitoring of 
myocardial function with a non-invasive method as 
echocardiography allows the detection of LV geometrical 
changes as LVEDD/w and LVmass/w increases and also a 
reduction in LVEF. The myocardial deformation analysis 
in the longitudinal axis (GLS) can be also detected. 
Geometrical and functional compromise precedes high 
mortality in acute CD and can be used as a prognostic 
function marker. A major proportion of dead animals 
present, before death, clinical signs of disease. Considering 
a proportionally significant non-vector transmission of CD, 
acute cases are still prevalent and if they are symptomatic, 
they should have cardiac function and geometry strictly 
monitored. 
CONCLUSION
Mortality in the acute phase of CD in the Syrian hamster 
animal model is high and timely related to the myocardial 
systolic dysfunction. Dysfunction can be detected with 
conventional echocardiography techniques such as LVEF 
quantification, and also with STE parameters as a reduction 
in the longitudinal deformation, measured by GLS. 
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